U.S. National Institutes of Health
Possible new mechanism suggested for estrogen's promotion of disease
Published in Women's Health Law Weekly, June 27th, 2004
Most studies of estrogen's ability to promote breast tumor growth have focused on mechanisms that increase tumor proliferation, but estrogen may also play a role in the regulation of angiogenesis, or blood vessel formation, suggest Hynda K. Kleinman, PhD, of the NIH's National Institute of Dental and Craniofacial Research, and colleagues.
Vascular endothelial growth factor (VEGF) and its two receptors, VEGFR-1 and VEGFR-2, play a regulatory role in angiogenesis. "VEGFR-2 is a positive angiogenic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Business Update
Dow Corning emerges from bankruptcy - Female Genital Mutilation
Burkina Faso: Circumcisers are operating on baby girls to evade law - German Cancer Research Center
Antisense oligonucleotides diminish breast cancer cell migration - Lahey Clinic, Northshore
Androgen insufficiency found in premenopausal women with sexual dysfunction - M.D. Anderson Cancer Center
Adding Herceptin to chemotherapy regimen boosts response rates in early disease - Pan American Health Organization
Air pollution affects preterm delivery and intrauterine growth restriction - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
